These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

419 related articles for article (PubMed ID: 28987593)

  • 21. MRGPRX2 activation as a rapid, high-throughput mechanistic-based approach for detecting peptide-mediated human mast cell degranulation liabilities.
    Lafleur MA; Werner J; Fort M; Lobenhofer EK; Balazs M; Goyos A
    J Immunotoxicol; 2020 Dec; 17(1):110-121. PubMed ID: 32525431
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of the dog orthologue of human MAS-related G protein coupled receptor X2 (MRGPRX2) essential for drug-induced pseudo-allergic reactions.
    Hamamura-Yasuno E; Iguchi T; Kumagai K; Tsuchiya Y; Mori K
    Sci Rep; 2020 Sep; 10(1):16146. PubMed ID: 32999394
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of a mast-cell-specific receptor crucial for pseudo-allergic drug reactions.
    McNeil BD; Pundir P; Meeker S; Han L; Undem BJ; Kulka M; Dong X
    Nature; 2015 Mar; 519(7542):237-41. PubMed ID: 25517090
    [TBL] [Abstract][Full Text] [Related]  

  • 24. DOCK2 regulates MRGPRX2/B2-mediated mast cell degranulation and drug-induced anaphylaxis.
    Kunimura K; Akiyoshi S; Uruno T; Matsubara K; Sakata D; Morino K; Hirotani K; Fukui Y
    J Allergy Clin Immunol; 2023 Jun; 151(6):1585-1594.e9. PubMed ID: 36804596
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gold induces a pseudo-allergic reaction via MRGPRX2 both in vitro and in vivo.
    Zeng Y; Wang J; Zhang Y; Ge S; Wu Y; Fan T; Wang N
    Cell Immunol; 2019 Jul; 341():103923. PubMed ID: 31076078
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dextromethorphan - A widely-used cough suppressant - Induces local anaphylaxis via MRGPRX2 on mast cells.
    Hu T; Hou Y; Lu J; Wang X; Wei D; Wang C
    Chem Biol Interact; 2020 Oct; 330():109248. PubMed ID: 32871113
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Thebaine induces anaphylactic reactions via the MRGPRX2 receptor pathway on mast cells.
    Lei P; Liu Y; Ding Y; Su X; Liang J; Chen H; Ma W
    Cell Immunol; 2022 May; 375():104514. PubMed ID: 35398603
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A novel MRGPRX2-targeting antagonistic DNA aptamer inhibits histamine release and prevents mast cell-mediated anaphylaxis.
    Suzuki Y; Liu S; Ogasawara T; Sawasaki T; Takasaki Y; Yorozuya T; Mogi M
    Eur J Pharmacol; 2020 Jul; 878():173104. PubMed ID: 32320700
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of MRGPRX2 but not FcεRI or MrgprB2-mediated mast cell degranulation by a small molecule inverse receptor agonist.
    Bawazir M; Amponnawarat A; Hui Y; Oskeritzian CA; Ali H
    Front Immunol; 2022; 13():1033794. PubMed ID: 36275683
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MRGPRX2 is critical for clozapine induced pseudo-allergic reactions.
    Wei D; Hu T; Hou YJ; Wang XJ; Lu JY; Ge S; Wang C; He HZ
    Immunopharmacol Immunotoxicol; 2021 Feb; 43(1):77-84. PubMed ID: 33327824
    [TBL] [Abstract][Full Text] [Related]  

  • 31. GRK2 inhibitors, paroxetine and CCG258747, attenuate IgE-mediated anaphylaxis but activate mast cells
    Thapaliya M; Amponnawarat A; Tesmer JJG; Ali H
    Front Immunol; 2022; 13():1032497. PubMed ID: 36275707
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MrgprX2 regulates mast cell degranulation through PI3K/AKT and PLCγ signaling in pseudo-allergic reactions.
    Zhang F; Hong F; Wang L; Fu R; Qi J; Yu B
    Int Immunopharmacol; 2022 Jan; 102():108389. PubMed ID: 34920312
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Imiquimod-related dermatitis is mainly mediated by mast cell degranulation via Mas-related G-protein coupled receptor B2.
    Hao Y; Peng B; Che D; Zheng Y; Kong S; Liu R; Shi J; Han H; Wang J; Cao J; Zhang Y; Gao J; He L; Geng S
    Int Immunopharmacol; 2020 Apr; 81():106258. PubMed ID: 32044660
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential Regulation of Mas-Related G Protein-Coupled Receptor X2-Mediated Mast Cell Degranulation by Antimicrobial Host Defense Peptides and Porphyromonas gingivalis Lipopolysaccharide.
    Gupta K; Idahosa C; Roy S; Lee D; Subramanian H; Dhingra A; Boesze-Battaglia K; Korostoff J; Ali H
    Infect Immun; 2017 Oct; 85(10):. PubMed ID: 28694291
    [No Abstract]   [Full Text] [Related]  

  • 35. Store-Operated Calcium Entry via STIM1 Contributes to MRGPRX2 Induced Mast Cell Functions.
    Occhiuto CJ; Kammala AK; Yang C; Nellutla R; Garcia M; Gomez G; Subramanian H
    Front Immunol; 2019; 10():3143. PubMed ID: 32038646
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reclassifying Anaphylaxis to Neuromuscular Blocking Agents Based on the Presumed Patho-Mechanism: IgE-Mediated, Pharmacological Adverse Reaction or "Innate Hypersensitivity"?
    Spoerl D; Nigolian H; Czarnetzki C; Harr T
    Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28590439
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MRGPRX2 Activation by Rocuronium: Insights from Studies with Human Skin Mast Cells and Missense Variants.
    Chompunud Na Ayudhya C; Amponnawarat A; Roy S; Oskeritzian CA; Ali H
    Cells; 2021 Jan; 10(1):. PubMed ID: 33467419
    [TBL] [Abstract][Full Text] [Related]  

  • 38. N-demethylsinomenine metabolite and its prototype sinomenine activate mast cells via MRGPRX2 and aggravate anaphylaxis.
    Qin Y; Huang Y; Ji X; Gong L; Luo S; Gao J; Liu R; Zhang T
    Front Pharmacol; 2024; 15():1389761. PubMed ID: 39144634
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human Mast Cell Line HMC1 Expresses Functional Mas-Related G-Protein Coupled Receptor 2.
    Hermans MAW; van Stigt AC; van de Meerendonk S; Schrijver B; van Daele PLA; van Hagen PM; van Splunter M; Dik WA
    Front Immunol; 2021; 12():625284. PubMed ID: 33790895
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mas-Related G Protein-Coupled Receptor-X2 (MRGPRX2) in Drug Hypersensitivity Reactions.
    Porebski G; Kwiecien K; Pawica M; Kwitniewski M
    Front Immunol; 2018; 9():3027. PubMed ID: 30619367
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.